• It seeks to achieve 50% reduction in mortality and disability caused by snakebite envenoming by 2030.
• Increasing the number of manufacturers by 25% and significantly boost production of quality antivenoms.
• Creating a global antivenom stockpile so as to ensure access to treatment like anti-venoms and ancillary medical care.

In many tropical and subtropical countries Snake bite is a neglected public health issue In 2017 World Health Organization (WHO) formally categorised “snakebite envenoming” as a Neglected Tropical Disease (NTD).